The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: a meta-analysis.

The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: a meta-analysis. Blood Coagul Fibrinolysis. 2016 Sep; 27(6):648-52.

View in: PubMed

subject areas

Antineoplastic Agents
Antineoplastic Agents
Humans
Humans
Janus Kinase 2
Janus Kinase 2
Nitriles
Nitriles
Odds Ratio
Odds Ratio
Polycythemia Vera
Polycythemia Vera
Primary Myelofibrosis
Primary Myelofibrosis
Protein Kinase Inhibitors
Protein Kinase Inhibitors
Pyrazoles
Pyrazoles
Pyrimidines
Pyrimidines
Randomized Controlled Trials as Topic
Randomized Controlled Trials as Topic
Risk
Risk
Thrombosis
Thrombosis
Treatment Outcome
Treatment Outcome

authors with profiles

Sara Vesely